Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2026-04-11 @ 3:53 PM
Study NCT ID:
NCT02116569
Status:
COMPLETED
Last Update Posted:
2016-09-26
First Post:
2014-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR104072
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None